Journal : Bioorg. Med. Chem. Lett.
Title : Synthesis and biological activities of NB-506 analogues modified at the glucose group.
Year : 2000
Volume : 10
Issue : 5
First Page : 419
Last Page : 422
Authors : Ohkubo M, Nishimura T, Kawamoto H, Nakano M, Honma T, Yoshinari T, Arakawa H, Suda H, Morishima H, Nishimura S.
Abstract : A new indolocarbazole compound, NB-506 (1), modified at the glucose group yielded a beta-D-glucopyranoside, J-107,088 (2), which showed potent anticancer activity. A beta-D-ribofuranoside, J-109,534 (3), was found to be 6 times more potent than J-107,088 at inhibiting topoisomerase I.